Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Vigilance Improves in People with Multiple Sclerosis (MS) and Fatigue following Repeated Dorsolateral Prefrontal Cortex Transcranial Direct Current Stimulation (tDCS) Sessions Paired with Cognitive Training Delivered at Home
Neuro-rehabilitation
S38 - Neuro-rehabilitation (3:54 PM-4:06 PM)
003

Fatigue in cognitive functioning is frequently reported in people with MS. Attentional vigilance, measured by response time and its variability across a period of sustained performance, can serve as an objective marker of self-reported cognitive fatigue. The dorsolateral prefrontal cortex (DLPFC) is a known substrate associated with self-reported fatigue and vigilance. 

To determine the efficacy of at-home transcranial direct current stimulation (tDCS) in people with multiple sclerosis (MS)-associated fatigue. 

People with MS and fatigue (Fatigue Severity Scale>36) and without severe cognitive impairment (z-score Symbol Digit Modality Test [SDMT] > -3.0) were enrolled in an open-label study to receive 20x20-minute daily at-home sessions of tDCS paired with adaptive cognitive training (aCT, Posit Science’s BrainHQ) using a remotely supervised protocol. Stimulation was administered over the DLPFC (anode F3, cathode F4) for 20 minutes at 2.0 mA. Attentional vigilance was measured by reaction time and variability on continuous performance tasks (Cogstate). Age was controlled by adjusting to normative z-scores to create a single composite vigilance z-score. 

Participants were n=24 (63% female, ages 22 to 71 years, and median Expanded Disability Status Scale (EDSS) score of 3.2 [1.0-6.5]). The intervention was safe and well tolerated, with n= 23/24 (96%) of them completing all 20 sessions. No significant improvement in SDMT was shown at the end of the intervention (-0.53±1.50 vs. -0.24±-1.45, p=0.101). However, the combined intervention of active tDCS and aCT led to an improvement in vigilance composite score (time and variability, mean z-score improvement: -0.89±1.94, p=0.036) as well as reaction time specific (mean detection (DET) z-score improvement: -0.46±1.02, p=0.038; mean identification (IDN) z-score improvement: -0.83±1.28, p=0.04).

Delivered as an at-home intervention, left DLPFC tDCS paired with aCT improves attentional vigilance in people with MS and fatigue. Vigilance can therefore provide an objective measure of cognitive fatigue in MS.

Authors/Disclosures
Giuseppina Pilloni, PhD (NYU Grossman School of Medicine)
PRESENTER
Dr. Pilloni has nothing to disclose.
Leigh E. Charvet, PhD (NYU Langone) Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
No disclosure on file
Claire Sunha Choi, MD Ms. Choi has nothing to disclose.
No disclosure on file
No disclosure on file
Lauren B. Krupp, MD, FAAN (NYU Langone Medical Center) Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.